Clinical trials
Phase 2 Hepatitis trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arbutus Biopharma Corporation | 1 |
| AusperBio Therapeutics Inc. | 1 |
| Brii Biosciences Limited | 1 |
| Gilead Sciences | 1 |
| Vir Biotechnology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis | 5 |
| Hepatitis B | 4 |
| Hepatitis B, Chronic | 4 |
| Blood-Borne Infections | 1 |
| Chronic Disease | 1 |
| Communicable Diseases | 1 |
| DNA Virus Infections | 1 |
| Digestive System Diseases | 1 |
| Disease Attributes | 1 |
| Hepatitis C | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.